Angesichts einer wachsenden Vielfalt an teuren Behandlungsmöglichkeiten und Medikamenten stellt die ökonomische Nachhaltigkeit eine besondere Herausforderung für Gesundheitssysteme mit universellem Versicherungsschutz dar. Ein bewährtes Mittel zur Kostendämpfung sind Zuzahlungen der...

Given the growing variety of expensive treatments and drugs, economic sustainability is a particular challenge for healthcare systems with universal insurance coverage. Patient co-payment regimes for prescription drugs are a proven means of cost containment worldwide. However, there is little...

Reference prices constitute a main determinant of patient health care reimbursement in many countries. We study the effects of a change from an external (based on a basket of prices in other countries) to an internal (based on comparable domestic products) reference price system. We find that...

Reference prices constitute a main determinant of patient health care reimbursement in many countries. We study the effects of a change from an "external" (based on a basket of prices in other countries) to an "internal" (based on comparable domestic products) reference price system. We find...

Reference prices constitute a main determinant of patient health care reimbursement in many countries. We study the effects of a change from an external (based on a basket of prices in other countries) to an internal (based on comparable domestic products) reference price system. We find that...